Close Menu

Pacific Biosciences' sequencer has made it from idea to tangible product, with its recent shipments of its PacBio RS instrument — though this BusinessWeek article points out that sequencing has been, and will continue to be, a challenging field for a company to make its mark on. However, PacBio is hopeful about its sequencing technology. "The ability to observe these things in real time has been the goal of modern biology for the last 50 years," says CSO Eric Schadt.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.